Danish Down's study recommends changes
This article was originally published in Clinica
Executive Summary
Denmark could succeed in cutting the number of children born with Down's syndrome from an average of 65 to 15 per year if current guidelines were revised to introduce serum screening and nuchal translucency ultrasound. A recent study on screening for Down's syndrome in Denmark 1980-98 claims that current screening methods based on age as a basis for invasive prenatal diagnostics mean that for every case avoided, two healthy foetuses are aborted. This is because invasive techniques, in this case chorionic villus sampling (CVS) and amniocentesis (AC), carry an inherent risk of a 1% spontaneous abortion rate, says the report.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.